Aprogen, 1st Korean biotech firm to get unicorn status
Aprogen has joined the list of unicorn companies, as the first Korean biotech firm.CB Insights, a U.S. market research firm, gave the unicorn status to Aprogen on Monday. A unicorn company refers to a firm with a valuation of over $1 billion before going public.Aprogen attracted 20 billion won ($16.
UK reviewer calls herbal medicine study for infertility ‘not science’
Kim Dong-il, director of Dongguk University Ilsan Oriental Hospital, recently requested Medicine, a review journal, to publish his paper on using herbal medicine and acupuncture to treat infertility. However, a U.K. researcher refused to peer review Kim’s paper, calling it “ludicrous” on his social
Roche Diagnostics to simplify non-invasive prenatal test in Korea
Roche Diagnostics Korea said it would promote the use of a non-invasive prenatal test (NIPT) in Korea.The company introduced its NIPT, called Harmony, in 2016 in the local market. The company used to utilize the “test and send out” (TSO) method to send extracted samples to U.S. test institutions and
Samsung execs get jail term for destroying evidence
A Seoul court gave jail terms to Samsung executives for destroying evidence in an investigation of alleged accounting fraud at Samsung BioLogics. However, the ruling had nothing to do with whether they were guilty or not of the alleged accounting fraud, the court noted.The Seoul Central District Cou
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
As preannounced by Biogen in October, its Alzheimer's drug candidate aducanumab has achieved significant efficacy at high doses.However, only one of the two phase 3 trials achieved p-values, and the high rate of discontinuation adverse reactions or amyloid-related imaging abnormalities compared